Dave has held roles as Director of Process Chemistry at AstraZeneca (Charnwood), and Vice President of Chemical Development at AMRI. He has been an independent process chemistry consultant since 2014.
Dave has over 25 years of industrial experience in the fine chemicals, agrochemicals, and pharmaceutical fields. Over the last 20 years he has worked in the pharmaceutical arena where he worked for SmithklineBeecham and AstraZeneca, where he was Director of Process Chemistry. He is a fellow of the Royal Society of Chemistry and a visiting Professor at Bristol University. In 2012 he was Chair of the Gordon Research Conference on Heterocyclic Compounds.
During his career he has worked on 4 marketed drugs including process re-development activities on “Seroquel” and “Paxil”. During his time at AstraZeneca, his team was responsible for the chemical development of "Iressa” and “Crestor”. Dave has been author or co-author on over 30 publications and patents.